Collecting cancer cells from blood in metastatic prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial is testing a blood-filtering procedure (leukapheresis) to collect special cancer cells that have broken away from the tumor. It may help doctors better understand your prostate cancer and guide future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and between 18 and 75 years old.
- Your prostate cancer has spread to other parts of the body (metastatic).
- You are in good overall health (ECOG score 0 or 1) and can tolerate a procedure called leukapheresis.
- Your blood counts, liver, and kidney function are normal.
- You have not received any cancer-fighting drugs or treatments in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood filtering procedure (apheresis) to collect prostate cancer cells from your blood for detailed analysis. It may help researchers understand why some prostate cancers spread, which could lead to better treatments. There are three groups: men with metastatic prostate cancer, men with PSA relapse after prostatectomy, and healthy volunteers.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This trial collects blood samples from adults with prostate cancer. It may help researchers learn more about the disease or how treatments work, without directly testing a new drug in the eligibility you provided.
This study collects blood samples from people with cancer and healthy volunteers to help researchers understand cancer better. Your blood will be used for laboratory studies that may improve future cancer treatments.
This trial studies prostate cancer cells in the blood (“circulating tumor cells”) while you undergo planned prostate surgery. It may help doctors better understand prostate cancer and how it behaves early, which could guide future treatment decisions.
This trial collects tumor samples from men with prostate cancer to study the bacteria and other microbes inside the tumor. It aims to learn how these microbes might affect the cancer and treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.